| Docs Dental Pr, Pc | |
|
606 Building Deport Rd Ft.buchanan PR 00934 | |
| (813) 451-4503 | |
| Not Available |
| Full Name | Docs Dental Pr, Pc |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 606 Building Deport Rd, Ft.buchanan, Puerto Rico |
| Authorized Official Name and Position | Amanda A Clark (DIRECTOR OF CREDENTIAING) |
| Authorized Official Contact | 8134514503 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Docs Dental Pr, Pc 6097 Easton Rd Pipersville PA 18947-1810 Ph: (813) 451-4503 | Docs Dental Pr, Pc 606 Building Deport Rd Ft.buchanan PR 00934 Ph: (813) 451-4503 |
| NPI Number | 1902487655 |
|---|---|
| Provider Enumeration Date | 04/15/2021 |
| Last Update Date | 04/15/2021 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902487655 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | (* (Not Available)) | Primary |
News Archive
The Health Professionals Follow-up Study (HPFS) is a prospective cohort study of 51,529 US male health professionals. During the follow up of these men between 1986 to 2006, published in the European Heart Journal, 1,818 men were confirmed with incident non-fatal myocardial infarction (MI) - a non fatal heart attack.
Lower outdoor temperatures are linked to an increase in the risk of heart attacks, according to a new study by scientists at the London School of Hygiene & Tropical Medicine (LSHTM).For the study (published in the British Medical Journal and released online today at bmj.com), the researcher, led by Krishnan Bhaskaran of LSHTM found that each 1°C reduction in temperature on a single day is associated with around 200 extra heart attacks.
With the number of COVID-19 cases and deaths increasing with each passing day, the need for a therapeutic or a vaccine for the pandemic intensifies.
Biovest International, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BiovaxID®, Biovest's personalized lymphoma vaccine. BiovaxID represents a new class of active immunotherapy and is one of the few select late-stage patient-specific cancer vaccines vying to be among the first to reach market.
› Verified 9 days ago